首页 | 本学科首页   官方微博 | 高级检索  
     

老年退行性心脏瓣膜病合并心力衰竭临床治疗探析
引用本文:匡时权. 老年退行性心脏瓣膜病合并心力衰竭临床治疗探析[J]. 心血管病防治知识, 2014, 0(2): 80-81
作者姓名:匡时权
作者单位:云南省大理学院附属医院,云南大理671000
摘    要:目的探讨老年退行性心脏瓣膜病合并心力衰竭的临床治疗。方法本次选择60例患者,随机分组就常规治疗(对照组)与加用血管紧张素转换酶抑制剂(观察组)的预后对比。结果观察组临床总有效率96.7%,明显高于对照组73.3%(P0.05)。结论老年退行性心脏瓣膜病合并心力衰竭采用血管紧张素转换酶抑制治疗,可提高预后,改善心功能,加快病情康复。

关 键 词:老年退行性心脏瓣膜病  合并  心力衰竭  临床治疗

Investigation of clinical treatment of senile degenerative valvular heart disease with heart failure
KUANG Shi-quan. Investigation of clinical treatment of senile degenerative valvular heart disease with heart failure[J]. , 2014, 0(2): 80-81
Authors:KUANG Shi-quan
Affiliation:KUANG Shi-quan(First Department of Internal Medicine, The Affiliated Hospital of Dali University, Dali 671000, Yunnan)
Abstract:Objective To investigate the clinical treatment of senile degenerative valvular heart disease with heart failure. Methods Sixty patients were randomized to conventional treatment (control group) and conventional treatment combined with angiotensin-converting enzyme (ACE) inhibitor (observation group). The two groups were compared in terms of treatment outcome. Results The observation group had a significantly higher overall response rate than the control group (96.7% vs 73.3%, P〈0.05). Conclusion ACE inhibitor can improve prognosis and cardiac function and promote recovery in the treatment of senile degenerative valvular heart disease with heart failure.
Keywords:Senile degenerative valvular heart disease  With  Heart failure  Clinical treatment
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号